Recalls

Dietary supplements recalled due to undeclared ingredients

Viagra single pack Dietary supplements recalled due to undeclared ingredientsSeveral dietary supplements marketed as male sexual enhancements are being recalled after testing by federal drug regulators found the products to contain undeclared sildenafil, the active drug ingredient in the erectile dysfunction drug Viagra. People who mistakenly take this drug are at risk for serious side effects, the Food and Drug Administration (FDA) warned.

“This undeclared active ingredient poses a threat to consumers because sildenafil may interact with nitrates found in some prescription drugs such as nitroglycerin and may lower blood pressure to dangerous levels. Consumers with diabetes, high blood pressure, high cholesterol, or heart disease often take nitrates,” the agency warned in a Drug Safety Announcement. “Additionally, the product may cause side effects, such as headaches and flushing.”

Viagra has also been linked to an increased risk of melanoma, the deadliest form of skin cancer.

The recall is being conduced by R. Thomas Marketing and include the following brands:

  • Black Ant: BIG BOX (20 small boxes / 4 capsules per box / 80 capsules total)
  • Herb Viagra: BIG BOX (20 small boxes / 4 capsules per box / 80 capsules)
  • Real Skill: BIG BOX (20 small boxes / 4 capsules per box / 80 capsules)
  • Stree Overlord: BIG BOX (20 small boxes / 4 capsules per box / 80 capsules)
  • Weekend Prince: BIG BOX (24 individual cards / 2 capsules per card/ 48 capsules)
  • African Black Ant: BIG BOX (8 small boxes / 6 capsules per box / 48 capsules)

The products were marketed as dietary supplements for male sexual enhancement. They were sold by R. Thomas Marketing via internet sales from September 2013 to present.

Consumers who have these products should stop using them immediately and arrange return to Attn: RECALL NOTICE, R Thomas Marketing LLC, 20 Passaic St., Trenton, NJ 08618.

Health care professionals and patients are encouraged to report any side effects related to use of any of these products to the FDA MedWatch Adverse Event Reporting Program at www.FDA.gov/MedWatch/Report.htm.

Source: FDA